South Africa’s Newest Billionaire Built a Pharmacy Empire
SOUTH AFRICA · WEALTH
Key Facts
—A new billionaire: The Bloomberg Billionaires Index ranked the Saltzman family for the first time in early July 2026, at about 1.3 billion dollars, roughly 23 billion rand.
—One store, 1978: Ivan and Lynette Saltzman, both pharmacists, bought a single pharmacy in Mondeor, south of Johannesburg, for 10,000 rand.
—The empire: Dis-Chem grew into a national health-and-beauty chain valued around 1.7 billion dollars, listed on the Johannesburg bourse since 2016.
—Exit at 75: Saltzman stepped back from his executive board role on June 30, 2026, having handed the chief executive job to Rui Morais in 2023.
—Family stake: The family still holds more than a quarter of the company after gifting shares to two of the founders’ sons.
—The test ahead: Bloomberg calls succession the real test of a chain built around its founder’s instincts.
Ivan Saltzman, the pharmacist who turned one Johannesburg dispensary into the Dis-Chem chain, is South Africa’s newest dollar billionaire: the Bloomberg Billionaires Index values his family at about 1.3 billion dollars, just as he retires at 75.
From Mondeor to a national chain
The story begins in 1978, when Ivan Saltzman and his wife Lynette, both qualified pharmacists, bought a small pharmacy in Mondeor, a modest suburb south of Johannesburg. They paid 10,000 rand for it.
From that single dispensary they built Dis-Chem into a national chain of pharmacy superstores, selling everything from prescriptions to vitamins, baby goods and beauty products. The company listed on the Johannesburg Stock Exchange in 2016 and is today valued at around 1.7 billion dollars.
The formula was volume and range under one roof, with the pharmacy counter as the anchor. It made Dis-Chem one of the country’s most recognisable retail brands.
The chain’s great rival is Clicks, the other giant of South African health retail. Between them, the two groups turned the corner pharmacy into one of the Johannesburg bourse’s steadiest sectors.
Ivan Saltzman’s exit and the handover
Saltzman gave up day-to-day command in July 2023, handing the chief executive role to Rui Morais, the group’s former chief financial officer. On June 30, 2026, at 75, he stepped back from his remaining executive board role.
Two days later came the milestone that made headlines: the Bloomberg Billionaires Index ranked the Saltzman family for the first time, at about 1.3 billion dollars, roughly 23 billion rand. That confirmed him as South Africa’s newest dollar billionaire, as Billionaires.Africa reported.
The couple prepared the ground years in advance, gifting company shares to two of their sons before retirement. The family retains more than a quarter of the business.
Lynette Saltzman, co-founder and a long-serving director, shaped the retail side of the business from its first days. The fortune is, by design, a family one.
What a pharmacy fortune says about South Africa
Saltzman’s rise is a distinctly South African wealth story: no mines, no banks, no political connections, just half a century of selling medicine and shampoo at scale. Health retail proved one of the economy’s most defensive corners, growing through recessions, load-shedding and a weak rand.
Dis-Chem also rode South Africans’ growing spend on wellness, from vitamins to in-store clinics. Health kept selling even when the wider economy did not.
His debut also refreshes a wealth register long dominated by the same names, from Johann Rupert’s luxury empire to mining dynasties. New money in South Africa increasingly comes from consumers, not commodities.
The listing in November 2016 was one of the Johannesburg exchange’s most anticipated retail debuts of that decade. It made the founders’ wealth visible long before the index formalised it.
It lands, too, in a week when the government confirmed it would not impose a wealth tax on the country’s richest, sparing fortunes like the Saltzmans’ a new levy.
The succession question
Bloomberg’s profile of the family frames what comes next as a test: can a chain built around one founder’s instincts thrive under professional management and inheriting children. Retail history is littered with founder-led empires that stumbled at exactly this point.
The early signs favour continuity, with Morais three years into the job and the family stake anchoring long-term ownership. But rivals are pressing, and South African consumers remain under strain.
There is a democratic quality to the fortune as well. It was assembled rand by rand at tills across the country, in full view of the customers who paid for it.
Saltzman leaves with the business intact, the fortune counted and the question open. For South Africa’s newest billionaire, the empire’s second act now belongs to others.
The index entry reads like a punctuation mark on a 48-year partnership between two pharmacists. What follows is a listed company’s story, not a family’s.
Frequently asked questions
Who is Ivan Saltzman?
He is the co-founder of Dis-Chem, South Africa’s health-and-beauty retail chain, which he started with his wife Lynette in 1978 by buying a single pharmacy in Mondeor, south of Johannesburg, for 10,000 rand.
How much is the Saltzman family worth?
The Bloomberg Billionaires Index ranked the family for the first time in early July 2026 at about 1.3 billion dollars, roughly 23 billion rand, making Ivan Saltzman South Africa’s newest dollar billionaire.
Who runs Dis-Chem now?
Rui Morais, the group’s former chief financial officer, has been chief executive since Ivan Saltzman stepped down from the role in July 2023. Saltzman left his remaining executive board role on June 30, 2026, at 75.
Why is succession a question for Dis-Chem?
The family still holds more than a quarter of the company after gifting shares to two of the founders’ sons, and Bloomberg notes the chain must now prove the founder-built formula works without its founder.
Connected Coverage
For more of South Africa’s wealth story, read how Pretoria rejected a wealth tax on its richest, how Johann Rupert crossed 20 billion dollars, and how Remgro won control of the Mediclinic hospital group.
Part of our ongoing coverage
Africa: The New Scramble — the great-power contest over the continent.
Read More from The Rio Times